CDNA · CareDx, Inc. · Documents
$88.92
+3.04 (+3.54%)
At close · Nov 3
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$4.51B
Shares
52.54M
Volume · Nov 3
1.59M
Avg daily vol (3M)
1.3M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 10-Q | CareDx reported $139 million revenue and $19 million net income for the three months ended September 30, 2026. It sold its lab products business to Eurobio for $171.7 million and acquired Naveris for $203.3 million. | 2026-10-29 | 2026-09-30 | |
| 8-K | CareDx reported third-quarter revenue of $139 million, up 39% year-over-year, and Adjusted EBITDA of $30 million. It raised 2026 revenue guidance to $520 million to $530 million and Adjusted EBITDA guidance to $90 million to $100 million. | 2026-10-29 | — | |
| 8-K/A | — | 2026-09-16 | 2026-06-30 | |
| 10-Q | — | 2026-07-30 | 2026-06-30 | |
| 8-K | — | 2026-07-30 | — | |
| 8-K | — | 2026-07-07 | 2026-06-30 | |
| 8-K | — | 2026-06-15 | 2026-06-11 | |
| DEFA14A | — | 2026-06-05 | — | |
| Investor Event Transcript | — | 2026-06-03 | 2026-06-30 | |
| S-3ASR | — | 2026-04-28 | — | |
| 8-K | — | 2026-04-28 | 2026-04-24 | |
| 10-Q | — | 2026-04-28 | 2026-03-31 | |
| ARS | — | 2026-04-27 | 2025-12-31 | |
| DEF 14A | — | 2026-04-27 | — | |
| DEFA14A | — | 2026-04-27 | — | |
| 8-K/A | — | 2026-04-23 | 2026-04-20 | |
| 8-K | — | 2026-04-16 | 2026-04-15 | |
| 10-K | — | 2026-02-25 | 2025-12-31 | |
| 8-K/A | — | 2026-02-25 | 2026-02-24 | |
| 8-K | — | 2026-02-24 | — | |
| 8-K | — | 2026-01-12 | — | |
| 8-K | — | 2025-12-18 | — | |
| 8-K | — | 2025-12-15 | — | |
| 8-K | — | 2025-11-04 | — | |
| 10-Q | — | 2025-11-04 | 2025-09-30 | |
| 8-K | — | 2025-10-24 | 2025-10-22 | |
| Investor Event Transcript | — | 2025-09-30 | — | |
| 8-K | — | 2025-08-06 | — | |
| 10-Q | — | 2025-08-06 | 2025-06-30 | |
| 8-K | — | 2025-06-12 | — | |
| 8-K | — | 2025-06-03 | — | |
| 10-Q | — | 2025-04-30 | 2025-03-31 | |
| 8-K | — | 2025-04-30 | — | |
| ARS | — | 2025-04-28 | 2024-12-31 | |
| DEFA14A | — | 2025-04-28 | — | |
| DEF 14A | — | 2025-04-28 | 2025-06-12 | |
| 8-K | — | 2025-03-28 | — | |
| 10-K | — | 2025-02-28 | 2024-12-31 | |
| 8-K | — | 2025-02-26 | — | |
| 8-K | — | 2025-01-13 | — | |
| 8-K | — | 2025-01-08 | 2025-01-06 | |
| 8-K | — | 2024-11-04 | — | |
| 10-Q | — | 2024-11-04 | 2024-09-30 | |
| 8-K | — | 2024-10-15 | — | |
| 8-K | — | 2024-10-08 | 2024-10-07 | |
| 8-K | — | 2024-10-04 | 2024-09-30 | |
| 8-K | — | 2024-09-12 | 2024-09-06 | |
| 10-Q | — | 2024-07-31 | 2024-06-30 | |
| 8-K | — | 2024-07-31 | — | |
| 8-K | — | 2024-06-18 | 2024-06-13 |
Showing 1–50 of 144 filings
Key facts
CIK
1217234
CUSIP
14167L103
13F (30d)
63 filings
62 filers
Visit website
Investor relations